BackBiotech Acquisition Co - Warrants (30/11/2027) Overview
Biotech Acquisition Co - Warrants (30/11/2027)

Biotech Acquisition Co - Warrants (30/11/2027) P/E Ratio

Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) has a P/E ratio of -0.96, below the sector sector average of 47.3.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-0.96

P/E Ratio

-0.96

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

Average P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) FAQ

As of the most recent data, BIOTW shows a P/E ratio of -0.96. That is below the sector sector average of 47.3. Scroll down for historical charts and peer comparison views.

The its sector sector average P/E ratio is about 47.3. Biotech Acquisition Co - Warrants (30/11/2027) is at -0.96, which is lower that average. That is roughly 102.0% below the sector mean. Use the comparison chart on this page to see how BIOTW stacks up against individual peers as well.

Investors watch BIOTW's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Biotech Acquisition Co - Warrants (30/11/2027)'s latest reading is -0.96. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Biotech Acquisition Co - Warrants (30/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -0.96) with ownership activity and broader fundamentals.